With over 20 years of hands-on experience in clinical research, regulatory affairs, and business development, I offer a rare, full-spectrum perspective on clinical trials. I’ve managed approximately 500 patients across all phases of research and have been involved in every step of the process — from identifying potential clients for CROs and handling complex submissions to Israeli regulatory authorities, to negotiating budgets and contracts with hospitals, and personally initiating and monitoring clinical studies.

My therapeutic experience spans a wide range of areas, including oncology, neurology, infectious diseases, rare diseases, endocrinology, hematology, rheumatology, respiratory diseases, pediatrics, dermatology, ophthalmology, immunology, cell and gene therapy, and studies combining medical devices with pharmaceuticals.

What sets me apart is my ability to bridge strategy and execution. I understand the operational challenges, regulatory demands, and commercial pressures — because I’ve lived them all. Whether supporting AI-driven initiatives to integrate real-world evidence or leading multi-site regulatory and start-up efforts, I bring a 360° understanding that ensures trials move forward efficiently, compliantly, and with real-world impact.